Temsirolimus Kit
Product Images NDC 16729-223

5 FDA label images from Accord Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Temsirolimus (NDC 16729-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (25 mg)

Principal Display Panel (25 mg)
Packaging label for Temsirolimus Injection 25 mg/mL per vial, a concentrated solution requiring two dilutions before administration. The kit contains one single-dose vial of Temsirolimus injection 25 mg/mL and one single-dose vial diluent for Temsirolimus injections. Manufactured for Accord Healthcare Inc. and by Intas Pharmaceuticals Limited in India. The label includes instructions to refrigerate and keep protected from light.*
FDA Label Image

Figure 1 (Temsirolimus Injection Figure)

Figure 1 (Temsirolimus Injection Figure)
A Kaplan-Meier survival curve chart comparing overall survival for Temsirolimus 25 mg versus Interferon. The x-axis represents months to death from randomization (0 to 30 months), and the y-axis indicates survival distribution function (0 to 1.0). Temsirolimus shows a higher survival probability over time compared to Interferon.*
FDA Label Image

Principal Display Panel (1.8 mL)

Principal Display Panel (1.8 mL)
Label for Temsirolimus Diluent for Injection kit by Accord Healthcare Inc., NDC 16729-222. Contains 2.2 mL diluent for dilution of Temsirolimus injection vial. Single-dose, refrigerated, Rx only. Includes manufacturer details and barcode.*
FDA Label Image

Principal Display Panel (25 mg/mL)

Principal Display Panel (25 mg/mL)
Label for Temsirolimus Injection 25 mg/mL kit by Accord Healthcare Inc., NDC 16729-221-30. The label states each vial contains 0.2 mL overfill with initial concentration of 10 mg/mL after dilution, requires dilution, single dose, refrigeration, and is Rx only. Includes barcode and manufacturing details.*
FDA Label Image

Structure (Temsirolimus Structure)

Structure (Temsirolimus Structure)
Chemical structure of temsirolimus. The diagram shows the molecular arrangement of atoms, including rings, hydroxyl groups, and multiple functional groups characteristic of the temsirolimus molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.